Cystic fibrosis: enhanced theophylline metabolism may be linked to the disease.
Theophylline disposition (5.5 mg/kg administered intravenously) was studied in 12 patients with cystic fibrosis (CF) and 16 healthy control volunteers. Dietary controls and logs were used to minimize the influence of food on theophylline metabolism. Control subjects were restudied in random order on two subsequent occasions after 2 weeks of either pancreatic enzymes or placebo. Theophylline and its three main metabolites, 1-methyluric acid, 3-methylxanthine, and 1,3-dimethyluric acid, were analyzed in serum and urine by HPLC. The total body clearance, renal clearance, nonrenal clearance, and volume of distribution of theophylline were significantly greater (p less than 0.05) in patients with CF than in control subjects. The increased nonrenal clearance was the result of increased biotransformation to each of the three main metabolites. Patients with CF exhibited enhanced N-demethylation and 8-hydroxylation of theophylline, pathways that appear to be mediated by two different families of P-450 enzymes. Theophylline clearance after 2 weeks of pancreatic enzyme administration in the control subjects was the same as with placebo. Possible reasons for enhanced theophylline biotransformation in CF are discussed.
D000293:Adolescent; D000328:Adult; D001711:Biotransformation; D002851:Chromatography, High Pressure Liquid; D002986:Clinical Trials as Topic; D003550:Cystic Fibrosis / Q000378:metabolism*; D004311:Double-Blind Method; D006801:Humans; D008297:Male; D011897:Random Allocation; D013806:Theophylline / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine; D014527:Uric Acid / Q000031:analogs & derivatives / Q000097:blood / Q000652:urine; D014970:Xanthines / Q000097:blood / Q000652:urine
D014970:Xanthines; D014527:Uric Acid; C030530:1-methyluric acid; D013806:Theophylline; C031274:1,3-dimethyluric acid; C029703:3-methylxanthine